Special Issue "Drug Design and Targeting"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 July 2011)
Prof. Dr. Nicholas Bodor
Center for Drug Discovery, University of Florida, P.O. Box 100497, Gainesville, FL 32610, USA
Phone: +1 305 868 8250
Fax: +1 305 868 3194
Interests: retrometabolic design; soft drugs; chemical-enzymatic targeting; computer assisted drug design; metabolism
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- soft drugs
- drug metabolism
- drug transport
- drug distribution
- retrometabolic design
- receptor binding
- analog design
- computer assisted drug design
- inclusion complexes
- controlled release
Pharmaceutics 2011, 3(4), 932-953; doi:10.3390/pharmaceutics3040932
Received: 18 September 2011; in revised form: 26 October 2011 / Accepted: 30 November 2011 / Published: 9 December 2011| Download PDF Full-text (931 KB) | Download XML Full-text
Last update: 11 November 2010